Stocks like Walgreens Boots Alliance Inc. [WBA] still have plenty of sunny days ahead

In yesterday’s Wall Street session, Walgreens Boots Alliance Inc. (NASDAQ:WBA) shares traded at $21.43, down -2.55% from the previous session.

As of this writing, 17 analysts cover Walgreens Boots Alliance Inc. (NASDAQ:WBA). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $26.00, we find $30.00. Given the previous closing price of $21.99, this indicates a potential upside of 36.43 percent. WBA stock price is now -23.83% away from the 50-day moving average and -35.95% away from the 200-day moving average. The market capitalization of the company currently stands at $18.54B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

There are 13 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $31.15 as their price target over the next twelve months.

With the price target reduced from $37 to $27, Morgan Stanley maintained Underweight rating for Walgreens Boots Alliance Inc. (NASDAQ: WBA).

In other news, Walgreens Boots Alliance, Inc., 10% Owner sold 1,320,858 shares of the company’s stock on Aug 03. The stock was sold for $250,000,115 at an average price of $189.27. Upon completion of the transaction, the 10% Owner now directly owns 31,769,546 shares in the company, valued at $680.82 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 30, EVP, Pres. U.S. Healthcare DRISCOLL JOHN PATRICK bought 5,172 shares of the business’s stock. A total of $146,984 was incurred on buying the stock at an average price of $28.42. This leaves the insider owning 59,050 shares of the company worth $1.27 million. Insiders disposed of 159,598 shares of company stock worth roughly $3.42 million over the past 1 year. A total of 0.30% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in WBA stock. A new stake in Walgreens Boots Alliance Inc. shares was purchased by CLEAR STREET LLC during the first quarter worth $8,572,000. TUDOR INVESTMENT CORP ET AL invested $8,237,000 in shares of WBA during the first quarter. In the first quarter, UNISUPER MANAGEMENT PTY LTD acquired a new stake in Walgreens Boots Alliance Inc. valued at approximately $7,534,000. ADAGE CAPITAL PARTNERS GP, L.L.C. acquired a new stake in WBA for approximately $7,020,000. CAPITAL FUND MANAGEMENT S.A. purchased a new stake in WBA valued at around $5,087,000 in the second quarter. In total, there are 1,575 active investors with 59.80% ownership of the company’s stock.

Monday morning saw Walgreens Boots Alliance Inc. (NASDAQ: WBA) opened at $22.15. During the past 12 months, Walgreens Boots Alliance Inc. has had a low of $21.92 and a high of $42.29. As of last week, the company has a debt-to-equity ratio of 0.61, a current ratio of 0.60, and a quick ratio of 0.30. The fifty day moving average price for WBA is $28.13 and a two-hundred day moving average price translates $33.46 for the stock.

The latest earnings results from Walgreens Boots Alliance Inc. (NASDAQ: WBA) was released for May, 2023. According to the Pharmaceutical Retailers Company, earnings per share came in at $1, missing analysts’ expectations of $1.07 by -0.07. This compares to $0.26 EPS in the same period last year. The net profit margin was -2.40% and return on equity was -15.10% for WBA. The company reported revenue of $35.41 billion for the quarter, compared to $32.6 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.64 percent. For the current quarter, analysts expect WBA to generate $34.74B in revenue.

Moreover, the firm recently paid out its quarterly dividend on 09/12/2023. Investors who held shares on 08/21/2023 were paid a $0.48 dividend. On an annualized basis, this represents a $1.92 dividend and a 8.96% percent yield. There was an ex-dividend date of 08/18/2023 for this dividend. In terms of dividend payout ratio, WBA is presently at 38.21%.

Walgreens Boots Alliance Inc.(WBA) Company Profile

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Related Posts